§483.80 Infection Control The facility must establish and maintain an infection prevention and control program designed to provide a safe, sanitary and comfortable environment and to help prevent the development and transmission of communicable diseases and infections.
§483.80(a) Infection prevention and control program. The facility must establish an infection prevention and control program (IPCP) that must include, at a minimum, the following elements:
§483.80(a)(1) A system for preventing, identifying, reporting, investigating, and controlling infections and communicable diseases for all residents, staff, volunteers, visitors, and other individuals providing services under a contractual arrangement based upon the facility assessment conducted according to §483.70(e) and following accepted national standards;
§483.80(a)(2) Written standards, policies, and procedures for the program, which must include, but are not limited to: (i) A system of surveillance designed to identify possible communicable diseases or infections before they can spread to other persons in the facility; (ii) When and to whom possible incidents of communicable disease or infections should be reported; (iii) Standard and transmission-based precautions to be followed to prevent spread of infections; (iv)When and how isolation should be used for a resident; including but not limited to: (A) The type and duration of the isolation, depending upon the infectious agent or organism involved, and (B) A requirement that the isolation should be the least restrictive possible for the resident under the circumstances. (v) The circumstances under which the facility must prohibit employees with a communicable disease or infected skin lesions from direct contact with residents or their food, if direct contact will transmit the disease; and (vi)The hand hygiene procedures to be followed by staff involved in direct resident contact.
§483.80(a)(4) A system for recording incidents identified under the facility's IPCP and the corrective actions taken by the facility.
§483.80(e) Linens. Personnel must handle, store, process, and transport linens so as to prevent the spread of infection.
§483.80(f) Annual review. The facility will conduct an annual review of its IPCP and update their program, as necessary.
|
Observations:
Based on observations, review of facility policies, review of facility documentation, clinical record reviews and interviews with residents and staff, it was determined that the facility failed to maintain an effective infection control program related to infection surveillance for three of five residents reviewed with infections (Residents R5, R16 and R56), infection data reporting and infection committee meetings as required.
Findings include:
Review of facility policy, "Infection Control Outcome and Process Surveillance and Reporting, dated revised March 1, 2024, revealed, "The Infection Preventionist will conduct regular outcome surveillance which consists of collecting/documenting data on individual cases and comparing collective data to standard, written definitions of infection."
Observation, on August 12, 2024, at 11:15 a.m. revealed that Resident R5 had a PICC line (peripherally inserted central catheter - a thin soft tube inserted in a vein in the arm with the tip of the tube positioned in a large vein that carries blood to the heart) in his right upper arm. Interview, at the time of the observation, Resident R5 stated that he received antibiotic therapy daily through his PICC line.
Review of Resident R5's Admission MDS (Minimum Data Set - a mandatory periodic resident assessment tool), dated July 28, 2024, revealed that the resident was admitted to the facility on July 21, 2024, and had diagnoses including osteomyelitis (bone infection) of the left ankle and foot. Continued review revealed that the resident had a surgical wound and was receiving IV medications and antibiotics.
Review of Medication Administration Records (MARs) for Resident R5 revealed a physician's order, dated July 22, 2024, for ceftriaxone (antibiotic medication) two grams, administer intravenously every 24 hours for infection until August 25, 2024. Continued review revealed that the medication was initiated on July 22, 2024, as prescribed and that the medication continued to be administered at the time of the survey.
Review of Resident R16's Admission MDS, dated July 31, 2024, revealed that the resident was admitted to the facility on July 24, 2024, with diagnoses including legal blindness. Continued review reveled that the resident was receiving antibiotic medications.
Review of July 2024 Medication Administration Records (MARs) for Resident R16 revealed a physician's order, dated July 24, 2024, for vancomycin (antibiotic medication) eye drops, instill one drop in right eye every two hours for vision loss until July 26, 2024. Continued review revealed a physician's order, dated July 24, 2024, for tobramycin (antibiotic medication) eye drops, instill one drop in right eye every two hours for vision loss until July 26, 2024.
Review of August 2024 Medication Administration Records (MARs) for Resident R16 revealed a physician's order, dated August 12, 2024, for azithromycin (antibiotic medication), give one tablet by mouth one time only for bronchitis (infection in the lungs) until August 12, 2024. Continued review revealed another physician's order, dated August 13, 2024, for azithromycin, give one tablet by mouth one time a day for bronchitis for two days.
Review of Resident R56's Admission MDS, dated July 28, 2024, revealed that the resident was admitted to the facility on July 13, 2024, with diagnoses including urinary tract infection. Continued review reveled that the resident was receiving antibiotic medications.
Review of MARs for Resident R56 revealed a physician's order, dated July 14, 2024, for Amoxicillin, give two capsules by mouth every eight hours for urinary tract infection for three days. Continued review revealed a physician's order, dated July 13, 2024, for methenamine Hippurate, give one tablet by mouth at bedtime for urinary antibiotic. The medication initiated on July 13, 2024, as prescribed and continued to be administered at the time of the survey.
Review of facility documentation pertaining to infection surveillance tracking logs for June, July and August 2024, revealed that Residents R5, R16 and R56 were not listed on the logs.
Interview on August 14, 2024, at 12:55 p.m. the Director of Nursing confirmed that infection surveillance and tracking had not been completed for Residents R5, R16 and R56.
Act 52 of 2007 mandates that nursing homes develop and implement comprehensive infection control plans and reporting of healthcare-associated infections as serious events. The Pennsylvania Patient Safety Reporting System (PA-PSRS) was created as a system for facilities to submit the required information.
During an interview on August 12, 2024, at 2:23 p.m. information pertaining to PA-PSRS utilization data and healthcare-associated infections reporting as well as infection committee meeting minutes and attendance was requested from the Nursing Home Administrator, Director of Nursing and Employee E3, Regional Nurse.
During a follow-up interview on August 13, 2024, at 12:21 p.m., the Director of Nursing and Employee E3, Regional Nurse, revealed that no one at the facility had access to the PA-PSRS system and that they were unable to provide any utilization or infection reporting data.
During a follow-up interview on August 15, 2024, at 12:55 p.m. the Nursing Home Administrator confirmed that she was unable to provide any current documentation at the time of the survey of infection committee meetings. Continued interview revealed that the last documented infection committee meeting was conducted in November 2023.
28 Pa Code 201.14(a) Responsibility of licensee
28 Pa Code 201.18(d) Management
| | Plan of Correction - To be completed: 10/02/2024
Residents 5, 16, and 56 were updated to be included in the infection surveillance An initial audit was completed to determine if current residents needed to be placed on infection surveillance for the last two weeks. If not present on the infection surveillance, the facility will update to include the resident identified. An initial audit of PA-PSRS for any unreported qualifying infection will be determined, if unreported the facility will ensure entered in PA-PSRS. DON or designee will provide education to licensed nursing staff on monitoring for new infections/antibiotics ordered by the physician to ensure infection surveillance is updated. The Director of Nursing/designee will conduct weekly random audits x 4 weeks and then monthly x 2 to ensure that current residents are placed on the infection surveillance report. Results of the audit will be reported to the Quality Assurance Performance Improvement Committee x 3 monthly. DON or designee will audit monthly x 3 the PA-PSRS reporting by the IP and ensure it is presented in the Infection Control Committee prior to QAPI. Results of the audit will be reported to the Quality Assurance Performance Improvement Committee x 3 monthly.
|
|